 Prevalence of depression<symptom> , anxiety<symptom> , and mood disorders among individuals with opioid use disorder far exceeds that of the general population. While psychiatric symptoms often improve upon entry into opioid treatment , this has typically been seen with treatments involving psychosocial counseling. In this secondary analysis , we examined changes in psychiatric symptoms during a randomized clinical trial evaluating an interim buprenorphine treatment without counseling among individuals awaiting entry into comprehensive treatment. Waitlisted adults with opioid use disorder (